CVAC Chart
See on advanced chart >
About
Curevac N.V. was incorporated pursuant to the laws of the Netherlandson April 7, 2020 . The company is a global clinical-stage biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid that has the...
Read More
- HighlightA biopharmaceutical company that develops mRNA-based vaccines and therapies for infectious diseases and cancer treatments
- ExchangeNASDAQ
- Listing Date08/14/2020
- Established Date04/07/2020
- Full-time Employees999
- AddressFriedrich-Miescher-Strasse 15 72076 Tubingen Germany
- Tel49-7071-98830
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Biotechnology